Skip to main content
. 2021 Jan 27;13(3):480. doi: 10.3390/cancers13030480

Figure 4.

Figure 4

BRN2 expression positively correlates with poor patient survival and is higher in patients with a basal-like subtype of breast cancer. (A) Kaplan–Meier plot showing that overall survival of breast cancer patients is correlated with BRN2 expression (0.1 FPKM cut-off; p-value, 3.651 × 10−3. (B) BRN2 gene expression in breast cancer tumors grouped as basal-like or hormone receptor-positive (p-value, 1.644 × 10−3). * p < 0.05.